Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Systemic Idiopathic Juvenile Arthritis - Overview
Systemic Idiopathic Juvenile Arthritis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Systemic Idiopathic Juvenile Arthritis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Systemic Idiopathic Juvenile Arthritis - Companies Involved in Therapeutics Development
BioXpress Therapeutics SA
Eli Lilly and Co
Jinyu Bio-technology Co Ltd
Johnson & Johnson
Mycex Biotech Inc
Regeneron Pharmaceuticals Inc
Systemic Idiopathic Juvenile Arthritis - Drug Profiles
adalimumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
baricitinib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CMAB-806 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
sarilumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Simponi Aria - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tocilizumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tocilizumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Systemic Idiopathic Juvenile Arthritis - Dormant Projects
Systemic Idiopathic Juvenile Arthritis - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Systemic Idiopathic Juvenile Arthritis, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Targets, H2 2019
Number of Products by Stage and Targets, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development for Systemic Idiopathic Juvenile Arthritis, H2 2019
Number of Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Systemic Idiopathic Juvenile Arthritis - Pipeline by BioXpress Therapeutics SA, H2 2019
Systemic Idiopathic Juvenile Arthritis - Pipeline by Eli Lilly and Co, H2 2019
Systemic Idiopathic Juvenile Arthritis - Pipeline by Jinyu Bio-technology Co Ltd, H2 2019
Systemic Idiopathic Juvenile Arthritis - Pipeline by Johnson & Johnson, H2 2019
Systemic Idiopathic Juvenile Arthritis - Pipeline by Mycenax Biotech Inc, H2 2019
Systemic Idiopathic Juvenile Arthritis - Pipeline by Regeneron Pharmaceuticals Inc, H2 2019
Systemic Idiopathic Juvenile Arthritis - Dormant Projects, H2 2019
Systemic Idiopathic Juvenile Arthritis - Discontinued Products, H2 2019